This company seems to have been delisted
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Reason: Acquired by Johnson & Johnson
Last recorded trade on: August 1, 2024
Source: https://www.jnj.com/media-center/press-releases/johnson-johnson-completes-acquisition-of-abiomed
Abiomed
ABMD
₹32,531
Share price
0.00%
Change (1 day)
N/A
Change (1 year)
Categories
Abiomed is an American medical devices company that develops and manufactures the circulatory support device Impella, the world’s smallest heart pump.
EPS for Abiomed (ABMD)
EPS in 2022 (TTM): ₹461.37
According to Abiomed's latest financial reports the company's current EPS (TTM) is ₹502.03. In 2021 the company made an earnings per share (EPS) of ₹250.16 a decrease over its 2020 EPS that were of ₹379.94.
EPS history for Abiomed from 2013 to 2022
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2022 (TTM) | ₹461.37 | 84.43% |
| 2021 | ₹250.16 | -34.16% |
| 2020 | ₹379.94 | -18.05% |
| 2019 | ₹463.61 | 9.48% |
| 2018 | ₹423.48 | 141.95% |
| 2017 | ₹175.03 | 81.42% |
| 2016 | ₹96.48 | -62.83% |
| 2015 | ₹259.56 | 575.56% |
| 2014 | ₹38.42 | 125% |
| 2013 | ₹17.08 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 | ₹734.27 | 46.26% | 🇺🇸 USA |
 | ₹70.01 | -86.05% | 🇺🇸 USA |
 | -₹46.11 | -109.18% | 🇺🇸 USA |